The drug firm Lupin has posted a 57.75% increase in its consolidated net profit to Rs 662.19 crore for the second quarter ended September 30.
Lupin has said in a BSE filing that the company had posted a net profit after taxes and minority interest of Rs 419.75 crore for the same period of the previous fiscal.
Company’s consolidated total income also increased to Rs 4,290.51 crore during the quarter under consideration as compared to Rs 3,329.67 crore in the corresponding period of last fiscal.
